Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The relationship between electric field strength induced by electroconvulsive therapy and cognitive and antidepressant outcomes
    Published on 2025-01-05
    11 months ago
  • Quantifying VMAT2 target occupancy at effective valbenazine doses and comparing to a novel VMAT2 inhibitor: a translational PET study
    Published on 2025-01-04
    11 months ago
  • In remembrance of Herbert Pardes, M.D. July 7, 1934–April 30, 2024
    Published on 2025-01-01
    11 months ago
  • Cigarette smoking is associated with reduced neuroinflammation and better cognitive control in people living with HIV
    Published on 2024-12-31
    11 months ago
  • Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials
    Published on 2024-12-29
    11 months ago
  • Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study
    Published on 2024-12-23
    12 months ago
  • Epac2-mediated synaptic insertion of Ca2+-permeable AMPARs in the nucleus accumbens contributes to incubation of cocaine craving
    Published on 2024-12-18
    12 months ago
« Previous 1 … 33 34 35 36 37 … 143 Next »
Journal of Psychopharmacology
  • The trace amine-associated receptor 1 agonists – non-dopaminergic antipsychotics or covert modulators of D2 receptors?
    Published on 2024-04-24
    2 years ago
  • Exploring psychedelic-assisted therapy in the treatment of functional seizures: A review of underlying mechanisms and associated brain networks
    Published on 2024-04-24
    2 years ago
  • Influence of GABAA and GABAB receptor activation on auditory sensory gating and its association with anxiety in healthy volunteers
    Published on 2024-04-22
    2 years ago
  • Mining and analysis of security alert signals of valbenazine based on the Food and Drug Administration Adverse Event Reporting System database
    Published on 2024-04-20
    2 years ago
  • Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants
    Published on 2024-04-15
    2 years ago
  • Psychedelics and the ‘inner healer’: Myth or mechanism?
    Published on 2024-04-12
    2 years ago
  • Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review
    Published on 2024-04-05
    2 years ago
« Previous 1 … 33 34 35 36 37 … 134 Next »
European Neuropsychopharmacology
  • Rare variants and clozapine: Reply
    Published on 2024-04-21
    2 years ago
  • Implementing cognitive screenings for outpatients with bipolar disorder following optimised treatment in a specialised mood disorder clinic
    Published on 2024-04-21
    2 years ago
  • Single-arm meta-analysis of drug response in placebo-controlled versus active-controlled antipsychotic drug trials in schizophrenia
    Published on 2024-04-21
    2 years ago
  • Antidepressants compared to placebo for people with binge eating disorder: A systematic review and meta-analysis
    Published on 2024-04-20
    2 years ago
  • Prescribing therapeutic apps within National Health Services: The critical role of evaluation and monitoring
    Published on 2024-04-20
    2 years ago
  • Chemical cousins with contrasting behavioural profiles: MDMA users and methamphetamine users differ in social-cognitive functions and aggression
    Published on 2024-04-20
    2 years ago
  • Antidepressant use in bipolar disorder: Shifting focus from ‘Whether’ to ‘Whom’
    Published on 2024-04-19
    2 years ago
« Previous 1 … 33 34 35 36 37 … 153 Next »

   Pharma Pub